- Home
- ROIV vs CBSH Comparison
ROIV vs CBSH Comparison
Compare ROIV & CBSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- CBSH
- Stock Information
- Founded
- ROIV 2014
- CBSH 1865
- Country
- ROIV United Kingdom
- CBSH United States
- Employees
- ROIV N/A
- CBSH N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- CBSH Major Banks
- Sector
- ROIV Health Care
- CBSH Finance
- Exchange
- ROIV Nasdaq
- CBSH Nasdaq
- Market Cap
- ROIV 7.8B
- CBSH 8.7B
- IPO Year
- ROIV N/A
- CBSH N/A
- Fundamental
- Price
- ROIV $11.44
- CBSH $64.63
- Analyst Decision
- ROIV Buy
- CBSH Hold
- Analyst Count
- ROIV 3
- CBSH 6
- Target Price
- ROIV $15.25
- CBSH $66.83
- AVG Volume (30 Days)
- ROIV 7.5M
- CBSH 884.5K
- Earning Date
- ROIV 08-07-2025
- CBSH 07-16-2025
- Dividend Yield
- ROIV N/A
- CBSH 1.70%
- EPS Growth
- ROIV N/A
- CBSH 17.70
- EPS
- ROIV N/A
- CBSH 4.14
- Revenue
- ROIV $29,053,000.00
- CBSH $1,672,233,000.00
- Revenue This Year
- ROIV $3.28
- CBSH $8.42
- Revenue Next Year
- ROIV $156.84
- CBSH $9.11
- P/E Ratio
- ROIV N/A
- CBSH $15.62
- Revenue Growth
- ROIV N/A
- CBSH 5.55
- 52 Week Low
- ROIV $8.73
- CBSH $52.69
- 52 Week High
- ROIV $13.06
- CBSH $72.75
- Technical
- Relative Strength Index (RSI)
- ROIV 53.12
- CBSH 55.72
- Support Level
- ROIV $10.71
- CBSH $62.55
- Resistance Level
- ROIV $11.78
- CBSH $66.31
- Average True Range (ATR)
- ROIV 0.29
- CBSH 1.34
- MACD
- ROIV 0.03
- CBSH -0.00
- Stochastic Oscillator
- ROIV 68.37
- CBSH 65.74
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About CBSH Commerce Bancshares Inc.
Commerce Bancshares Inc operates as the bank holding company for Commerce Bank. The bank is engaged in the general banking business, providing a broad range of retail, mortgage banking, corporate, investment, trust, and asset management products and services to individuals, businesses, and municipalities. It operates through three segments: Consumer, Commercial, and Wealth. The Commercial segment provides corporate lending, payment solutions, leasing, international services, and business banking. The Consumer segment covers retail banking, mortgages, installment lending, and card services. The Wealth segment offers trust and estate planning, brokerage, and investment management services.